Pepdox
Studies
Peptides
Calculator
Does Semaglutide Reduce Kidney Disease Events on Top of SGLT2 Inhibitors in Patients with CKD and T2D? | Pepdox
Home
/
Search
/
PMID 38838981
Does Semaglutide Reduce Kidney Disease Events on Top of SGLT2 Inhibitors in Patients with CKD and T2D?
Journal of cardiac failure
2024
PMID: 38838981
View on PubMed
DOI: 10.1016/j.cardfail.2024.05.006
Semaglutide
Authors
Ferreira, João Pedro; Mendonça, Luís; Neves, João Sérgio
Keywords
Semaglutide, SGLT2 inhibitor, type 2 diabetes
chronic kidney disease